Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Vitamin D Deficiency and Risk of Cardiovascular Disease
2008 Standout
N-Terminal Pro–B-Type Natriuretic Peptide Testing Improves the Management of Patients With Suspected Acute Heart Failure
2007
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
2006 StandoutNobel
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Loss of Hypoxia-Inducible Factor Prolyl Hydroxylase Activity in Cardiomyocytes Phenocopies Ischemic Cardiomyopathy
2010 StandoutNobel
A Comparison of Criterion Standard Methods to Diagnose Acute Heart Failure
2012
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study
2009 Standout
Galectin 3 complements BNP in risk stratification in acute heart failure
2012
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Universal Definition of Myocardial Infarction
2007 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Plasma pro-B-type natriuretic peptide in the general population: screening for left ventricular hypertrophy and systolic dysfunction
2006
The Failing Heart — An Engine Out of Fuel
2007 Standout
N‐terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism
2003
Clinical, Neurohormonal, and Inflammatory Markers and Overall Prognostic Role of Chronic Obstructive Pulmonary Disease in Patients With Heart Failure: Data From the Val-HeFT Heart Failure Trial
2007
Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension
2010 Standout
The metabolic syndrome
2010 Standout
Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association
2019
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
2009 Standout
B-type natriuretic peptide in cardiovascular disease
2003
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Utilization of Cardiac Biomarker Testing in Heart Failure
2007
Reduction in BNP Levels With Treatment of Decompensated Heart Failure and Future Clinical Events
2008
Comparison of echocardiography and plasma B-type natriuretic peptide for monitoring the response to treatment in acute heart failure
2004
Natriuretic Peptides, Respiratory Disease, and the Right Heart
2004
The REDCap consortium: Building an international community of software platform partners
2019 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
2017 Standout
Use of BNP and NT-proBNP for the diagnosis of heart failure in the emergency department: a systematic review of the evidence
2014
Point-of-Care Ultrasonography
2011 Standout
Optimal Pharmacologic and Non-pharmacologic Management of Cardiac Transplant Candidates: Approaches to Be Considered Prior to Transplant Evaluation: International Society for Heart and Lung Transplantation Guidelines for the Care of Cardiac Transplant Candidates—2006
2006
Amino-Terminal Pro-B-Type Natriuretic Peptide and B-Type Natriuretic Peptide in the General Community
2006
Diagnostic accuracy of BNP and NT-proBNP in patients presenting to acute care settings with dyspnea: A systematic review
2007
Acute kidney injury
2019 Standout
The metabolic syndrome
2005 Standout
Prognostic Importance of Pulmonary Hypertension in Patients With Heart Failure
2007
Relationship Between B-Type Natriuretic Peptides and Pulmonary Capillary Wedge Pressure in the Intensive Care Unit
2005
Emergency Thoracic Ultrasound in the Differentiation of the Etiology of Shortness of Breath (ETUDES): Sonographic B-lines and N-terminal Pro-brain-type Natriuretic Peptide in Diagnosing Congestive Heart Failure
2009
US Trends in Prevalence, Awareness, Treatment, and Control of Hypertension, 1988-2008
2010 Standout
Myocarditis
2011 Standout
Early Ultrafiltration in Patients With Decompensated Heart Failure and Diuretic Resistance
2005
Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy
2013 Standout
Natriuretic Peptides
2007
Recommendations for the use of natriuretic peptides in acute cardiac care: A position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care
2011
Sepsis-Associated Myocardial Dysfunction
2006
Biomarkers in Acute Cardiac Disease
2006
The use of B‐type natriuretic peptide in the management of elderly patients with acute dyspnoea
2005
Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease
2005
Heart failure
2005
Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT)
2004
Alzheimer's Disease
2010 Standout
Obesity and suppressed B-type natriuretic peptide levels in heart failure
2004
The N-terminal Pro-BNP Investigation of Dyspnea in the Emergency department (PRIDE) study
2005
Use of B-Type Natriuretic Peptide in the Evaluation and Management of Acute Dyspnea
2004
Third Universal Definition of Myocardial Infarction
2012 Standout
The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT
2004
One statistical test is sufficient for assessing new predictive markers
2011
Ultrafiltration Versus Usual Care for Hospitalized Patients With Heart Failure
2005
Ultrafiltration Versus Intravenous Diuretics for Patients Hospitalized for Acute Decompensated Heart Failure
2007
Plasma Brain Natriuretic Peptide-Guided Therapy to Improve Outcome in Heart Failure
2007
B-type natriuretic peptide-guided versus symptom-guided therapy in outpatients with chronic heart failure
2014
Biomarkers in Heart Failure
2008 Standout
Physician Competencies for Prescribing Lifestyle Medicine
2010 Standout
Molecular Regulation of Vascular Smooth Muscle Cell Differentiation in Development and Disease
2004 Standout
Renal Function, Congestive Heart Failure, and Amino-Terminal Pro-Brain Natriuretic Peptide Measurement
2005
Adipose Tissue as an Endocrine Organ
2004 Standout
New Roles for β-Arrestins in Cell Signaling: Not Just for Seven-Transmembrane Receptors
2006 StandoutNobel
B-Type Natriuretic Peptide (BNP) and Amino-Terminal proBNP in Patients With CKD: Relationship to Renal Function and Left Ventricular Hypertrophy
2005
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
2010 Standout
The prognostic importance of lung function in patients admitted with heart failure
2010
Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology
2009
N‐terminal probrain natriuretic peptide (NT‐proBNP) in the emergency diagnosis and in‐hospital monitoring of patients with dyspnoea and ventricular dysfunction
2004
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
2005 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update
2006 Standout
Clinical iron deficiency disturbs normal human responses to hypoxia
2016 StandoutNobel
Gender Differences in the Management and Clinical Outcome of Stable Angina
2006
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial
2010 Standout
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
Admission, Discharge, or Change in B-Type Natriuretic Peptide and Long-Term Outcomes
2011
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009
Clinical Policy: Critical Issues in the Evaluation and Management of Adult Patients Presenting to the Emergency Department with Acute Heart Failure Syndromes
2007
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Forecasting the Future of Cardiovascular Disease in the United States
2011 Standout
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Impact of Chronic Obstructive Pulmonary Disease on Long-Term Outcome of Patients Hospitalized for Heart Failure
2007
Fine-Particulate Air Pollution and Life Expectancy in the United States
2009 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Novel markers for heart failure diagnosis and prognosis
2005
Right Ventricular Function in Cardiovascular Disease, Part I
2008 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Determinants of Serum High Molecular Weight (HMW) Adiponectin Levels in Patients with Coronary Artery Disease: Associations with Cardio-renal-anemia Syndrome
2011
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
Interpreting Cardiac Biomarkers in the Setting of Chronic Kidney Disease
2016
Differential Expression of Cardiac Biomarkers by Gender in Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2004
Global burden of heart failure: a comprehensive and updated review of epidemiology
2022 Standout
Rapid Emergency Department Heart Failure Outpatients Trial (REDHOT II)
2009
Recommendations for Blood Pressure Measurement in Humans and Experimental Animals
2005 Standout
Works of Sumant Lamba being referenced
Peripherally inserted veno-venous ultrafiltration for rapid treatment of volume overloaded patients
2003
Uncovering Heart Failure in Patients with a History of Pulmonary Disease: Rationale for the Early Use of B-type Natriuretic Peptide in the Emergency Department
2003
B-type natriuretic peptide and renal function in the diagnosis of heart failure: An analysis from the breathing not properly multinational study
2003
B-Type Natriuretic Peptide and Clinical Judgment in Emergency Diagnosis of Heart Failure
2002
What is in the differential diagnosis of a B-type natriuretic peptide level of 1,000 pg/ml?
2003
Uncovering Heart Failure in Patients with a History of Pulmonary Disease: Rationale for the Early Use of B‐type Natriuretic Peptide in the Emergency Department
2003